Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma

European Journal of Cardio-thoracic Surgery

Volumn 29, Issue 4, 2006, Pages 579-584

  Opitz, Isabelle ^a   Kestenholz, Peter ^a   Lardinois, Didier ^a   Müller, Michael ^a   Rousson, Valentin ^b   Schneiter, Didier ^a   Stahel, Rolf ^a   Weder, Walter ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Institute for Biostatistics and Preventive Medicine   (Switzerland)

Author keywords

Complications; EORTC score; Extrapleural pneumonectomy; Malignant pleural mesothelioma; Neoadjuvant chemotherapy

Indexed keywords

AMIODARONE; AMOXICILLIN PLUS CLAVULANIC ACID; CISPLATIN; GEMCITABINE; NETILMICIN; PEMETREXED; VANCOMYCIN;

BRONCHOPLEURAL FISTULA; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CHYLOTHORAX; COMPUTER ASSISTED RADIOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; EMPYEMA; FEMALE; FORWARD HEART FAILURE; HEMATOLOGIC DISEASE; HIATUS HERNIA; HUMAN; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROLOGIC DISEASE; PLEURA EMPYEMA; PLEURA MESOTHELIOMA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL MORTALITY; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BRONCHIAL FISTULA; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DEOXYCYTIDINE; FEMALE; FISTULA; GLUTAMATES; GUANINE; HUMANS; INTRAOPERATIVE PERIOD; LENGTH OF STAY; MALE; MESOTHELIOMA; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PLEURAL DISEASES; PLEURAL NEOPLASMS; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 33644981022     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejcts.2006.01.015     Document Type: Conference Paper

References (21)

1. J. Peto, A. Decarli, C. La Vecchia, F. Levi, and E. Negri The European mesothelioma epidemic Br J Cancer 79 3-4 1999 666 672
2. V. DeVita, S. Hellman, and S. Rosneberg Cancer: principles and practice of oncology 6th ed. 2001 Lippincott Williams & Wilkins Philadelphia
3. E. Butchart, T. Ashcroft, W. Barnsley, and M. Holden Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients Thorax 31 1 1976 15 24
4. D.J. Sugarbaker, M.T. Jaklitsch, R. Bueno, W. Richards, J. Lukanich, S.J. Mentzer, Y. Colson, P. Linden, M. Chang, and L. Capalbo Prevention, early detection, and management of complications after 328 consecutive extrapleural pneumonectomies J Thorac Cardiovasc Surg 128 1 2004 138 146
5. V.W. Rusch, S. Piantadosi, and E.C. Holmes The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial J Thorac Cardiovasc Surg 102 1 1991 1 9
6. K. Allen, L. Faber, and W. Warren Malignant pleural mesothelioma. Extrapleural pneumonectomy and pleurectomy Chest Surg Clin North Am 4 1 1994 113 126
7. D.J. Stewart, A.E. Martin-Ucar, J.G. Edwards, K. West, and D.A. Waller Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations Eur J Cardio-thorac Surg 27 3 2005 373 378
8. W. Weder, P. Kestenholz, C. Taverna, S. Bodis, D. Lardinois, M. Jerman, and R.A. Stahel Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma J Clin Oncol 22 17 2004 3451 3457
9. M. Oken, R. Creech, D. Tormey, J. Horton, T. Davis, E. Mc Fadden, and P. Carbone Toxicity and response criteria of the Eastern Cooperative Oncology Group Am J Clin Oncol 5 1982 649 655
10. R. Stahel, W. Weder, P. Ballabeni, D. Betticher, R. Schmid, R. Stupp, H.B. Ris, A. Roth, W. Mingrone, S. Bodis, and SGfCCR (SAKK) Neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma (MPM): a multicenter phase II trial of the SAKK J Clin Oncol 22 14S 2004 7052
11. M.J. Byrne, and A.K. Nowak Modified RECIST criteria for assessment of response in malignant pleural mesothelioma Ann Oncol 15 2 2004 257 260
12. V. Rusch A proposed new international staging system for malignant pleural mesothelioma from the international mesothelioma interest group Lung Cancer 14 1996 1 12
13. D.A. Fennell, A. Parmar, J. Shamash, M.T. Evans, M.T. Sheaff, R. Sylvester, K. Dhaliwal, N. Gower, J. Steele, and R. Rudd Statistical Validation of the EORTC Prognostic Model for Malignant Pleural Mesothelioma Based on Three Consecutive Phase II Trials J Clin Oncol 23 1 2005 184 189
14. D. Schneiter, P. Cassina, S. Korom, I. Inci, M. Al-Abdullatief, A. Dutly, P. Kestenholz, and W. Weder Accelerated treatment for early and late postpneumonectomy empyema Ann Thorac Surg 72 5 2001 1668 1672
15. R. Ginsberg, L. Hill, and R. Eagan Modern thirty-day operative mortality for surgical resections in lung cancer J Thorac Cardiovasc Surg 99 1983 218 226
16. O. Clagett, and J. Geraci A procedure for the management of post-pneumonectomy empyema J Thorac Cardiovasc Surg 45 1963 141
17. J.F. Regnard, M. Alifano, P. Puyo, E. Fares, P. Magdeleinat, and P. Levasseur Open window thoracostomy followed by intrathoracic flap transposition in the treatment of empyema complicating pulmonary resection J Thorac Cardiovasc Surg 120 2 2000 270 275
18. G. Crosthwaite, B. Joypaul, and A. Cuschieri Thoracoscopic management of thoracic duct injury J R Coll Surg Edinb 40 1995 303 304
19. G. Patterson, T. Todd, N. Dekarue, R. Ilves, F. Pearson, and J. Cooper Supradiaphragmatic ligation of the thoracic duct in intractable chylous fistula Ann Thorac Surg 32 1981 44 49
20. J. Harpole, H. David, M.J. Liptay, J. DeCamp, M. Malcolm, S.J. Mentzer, S.J. Swanson, and D.J. Sugarbaker Prospective analysis of pneumonectomy: Risk factors for major morbidity and cardiac dysrhythmias The Annals of Thoracic Surgery 61 3 1996 977 982
21. A.A. Vaporciyan, A.M. Correa, D.C. Rice, J.A. Roth, W.R. Smythe, S.G. Swisher, G.L. Walsh, J. Putnam, and B. Joe Risk factors associated with atrial fibrillation after noncardiac thoracic surgery: analysis of 2588 patients J Thorac Cardiovasc Surg 127 3 2004 779 786